Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

Once a suspect COVID cure, now a right-wing aspirin. As a physician who diagnoses cancer, I have come across this line of ...

The documents show that blockbuster cancer drugs like pembrolizumab (brand Keytruda), osimertinib (brand Tagrisso), and ...

Alongside her husband, Bob Duggan, Maky Zanganeh has guided cancer drug developer Summit Therapeutics to reach staggering new ...

Johnson & Johnson has projected its lung cancer drug Rybrevant could achieve $5 billion in peak revenue. At the recent ASCO annual meeting, J&J executive Joshua Bauml explained his company’s ...

New data indicate a targeted drug from Nuvalent could help patients with a rare lung cancer for whom other drugs stopped working ...

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% ...

Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical, and lung cancer. Yet producing the drug is complex, costly, and environmentally burdensome, as it ...

The list recommending customs duty of 5% includes 74 drugs, while another suggesting full exemption has 69 drugs. A separate ...

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its developer calls a clinical first. Insilico Medicine, the biotech company ...

Merck’s Keytruda is the world’s top-selling drug, bringing in nearly $30 billion in sales last year. The drug, which is used to treat lung cancer, melanoma and certain other cancers, has ...

In a retrospective review of 301 consecutive lung transplants, the 34 lung recipients taking a GLP-1 drug for diabetes or obesity early in their post-transplant course had 15.19-fold (95% CI 2.08 ...